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Liver ischemia-reperfusion (I/R) injury occurs during transplantation andmajor hepatic surgery, whichmay lead to postoperative liver
dysfunction. More and more traditional Chinese medicines (TCMs) have been used to treat liver ischemia-reperfusion injury. .e
purpose of this review is to evaluate the different protective effects of TCMs in the treatment of liver ischemia-reperfusion injury and to
summarize its possible mechanisms. .e results indicate that TCMs attenuate liver I/R injury via multiple mechanisms, including
antioxidation stress, anti-inflammatory response, antiapoptosis, and inhibiting endoplasmic reticulum stress. However, the in-depth
mechanism of the protective effects of these traditional Chinese medicines still remains unknown.
1. Introduction
Ischemia-reperfusion (I/R) injury is a two-stage phe-
nomenon in which blood flow into the organ is reduced,
leading to tissue hypoxia and cell damage, followed by
aggravated injury when oxygen delivery is restored [1].
Liver ischemia-reperfusion injury (I/RI) occurs during
transplantation and major hepatic surgery, which may
result in postoperative liver dysfunction [2, 3]. .e ces-
sation of blood flow to an organ can lead to oxygen and
nutrient deficiencies which can induce inflammatory cell
infiltration, production of oxygen-derived reactive oxygen
species (ROS) and nitrogen-derived reactive nitrogen
species, and process during the reperfusion period [4].
Reperfusion injury mainly comes from toxic ROS produced
by ischemic tissue when oxygen is reintroduced. ROS can
be derived intracellularly and extracellularly, and mito-
chondria in liver cells are the main source of ROS [5].
Herbal medicine has drawn more and more attention in
recent years. According to the World Health Organization,
approximately 80% of the global population relies on tra-
ditional herbal medicines as part of standard health care [6].
A series of traditional Chinese medicine ingredients have
been used to treat liver ischemia-reperfusion injury and have
achieved good results (see Table 1). However, traditional
Chinese medicine is a multicomponent medicine and plays
an effective role through multiple targets and pathways,
including antioxidation stress, anti-inflammatory response,
antiapoptosis, and inhibiting endoplasmic reticulum stress.
In this review, we summarize the effects of TCMs on I/R-
induced liver injury, with focus on the possible underlying
mechanisms.
2. The Protective Effect of TCMs on Liver
Ischemia-Reperfusion Injury and
Potential Mechanisms
During I/R, some functional changes that occur at the
cellular level may cause cell damage via production of ROS,
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inflammatory cytokines, and chemokines. .ese events
trigger the apoptotic pathway and ultimately lead to organ
failure [24]. According to current researches, the pro-
tective effect of TCMs on liver I/R is mainly involved in
several mechanisms: antioxidation stress, anti-inflammatory
response, antiapoptosis, and inhibiting endoplasmic re-
ticulum stress. Also, there are two main models used
in animal experiments: the hepatic I/RI model and liver
transplantation model.
2.1. Antioxidative Stress. It is well known that oxidative
stress and reactive oxygen intermediates play important
roles in liver ischemia-reperfusion injury. Free radicals
formed by oxidative stress damage the cell membrane of
hepatocytes through lipid peroxidation or/and other means.
Furthermore, these free radicals can cause extensive damage
to DNA and proteins, which can eventually lead to acute and
chronic liver damage [25–27]. Lots of research studies are
focused on antioxidant compounds extracted from herbal






















— Pan et al.[8]





















































































































































Wistar rats Inhibiting endoplasmicreticulum stress —
Zhang
et al. [23]
2 Evidence-Based Complementary and Alternative Medicine
medicines to address the mechanism of its clinical protective
effect to liver I/R injury.
In I/RI model rats, Atractylodes macrocephala polysac-
charide (AMP), the principal bioactive component of
Atractylodes macrocephala, significantly inhibited lipid
peroxidation and altered the activities of the antioxidant
enzyme, superoxide dismutase, and malondialdehyde level,
which is associated with its antioxidant properties and in-
hibition of NF-κB activation [7]. Saffron ethanol extract
(SEE) contains abundant flavonoid compounds with anti-
oxidant effect [28]. A study found that SEE could reduce
liver IR damage by scavenging free radicals, maintaining
physiological ROS level, and attenuating oxidation-medi-
ated chaperone carbonylation [8]. Mitochondria are the
main source of ROS in cells. Mitochondrial damage leads to
an increase in ROS production, which results in oxida-
tive stress [29]. Mitofusin 2 (Mfn2), located in the outer
mitochondrial membrane, has the function of controlling
mitochondrial metabolism [30]. Lou et al. found that bre-
viscapine, a flavonoid compound extracted from the natural
plant Erigeron breviscapus [31], could attenuate liver I/R
injury by reducing lipid peroxidation and downregulating
the expression of Mfn2 via inhibiting the Ras-PI3K-Akt
pathway [9]. Caffeic acid (CA), a single phenolic acid derived
from Salvia miltiorrhiza [32], is associated with chondrio-
some. It was found to have a protective effect on I/RI by
reducing liver microcirculation disturbance and oxidative
damage through regulating Sirt3 and the mitochondrial
respiratory chain [10]. Further research shows that PDIA3
(protein disulfide isomerase A3) activates NADPH oxidase
and causes the burst of ROS. CA may protect the trans-
planted liver by inhibiting PDIA3-NADPH oxidase [11].
TCMs exert hepatic ischemia-reperfusion injury protection
through antioxidative stress which is also observed in
huperzine A (HupA), gypenoside (GP), and glycyrrhizin
(GL) [14–16].
2.2. Anti-Inflammatory Response. .e liver undergoes a
strong inflammatory process during ischemia and reper-
fusion injury..is liver inflammation is initially triggered by
ischemia. However, the inflammation mainly occurs during
the reperfusion phase and is characterized by the recruit-
ment of large numbers of neutrophils in the liver. .e
production of cytokines, chemokines, and danger signals
activates resident liver cells, white blood cells, and Kupffer
cells [33]. .e following research studies have authenticated
that TCMs attenuate liver ischemia and reperfusion injury
through an anti-inflammatory response pathway.
Ischemia reperfusion is considered to be a complex
cascade of inflammatory mediators involved in the patho-
genesis of liver injury. Different from caffeic acid, although
magnesium lithospermate B (MLB) and Tanshinone IIA
(Tan IIA) are also the main components of Salvia miltior-
rhiza, they mainly exert anti-inflammatory effects. MLB can
prevent the activation of inflammatory signaling pathways,
reduce the expression of inflammatory mediators, and de-
crease the infiltration of macrophages and neutrophils,
thereby reducing the damage of liver cells induced by IR
[12]. It was reported that IL-17 contributes to the ac-
cumulation of neutrophils in the inflammatory liver.
Triptolide, a purified ingredient of shrub-like vine Tripterygium
wilfondii Hook F, can reduce the expression of IL-17 by
inhibiting transcription 3 (STAT3) phosphorylation, thereby
inhibiting the recruitment of neutrophils in the process of
liver I/R [17]. In addition, there is evidence that Tan IIA
pretreatment can reduce inflammation infiltration and liver
damage. .e underlying mechanism may be that Tan IIA
inhibits the Toll-like receptors 4 (TLR4) signaling path-
way, thereby enhancing the expression of HO-1 and re-
ducing the expression of liver proinflammatory cytokines
[13]. In Xiao’s experiment, puerarin nanoparticle synthesis
significantly decreased the TLR4 and NF-κB expressions,
which showed that puerarin can display its protective role
by restraining the activation of proinflammatory factors
through the TLR4/NF-κB fashion [18].
Proinflammatory cytokines such as TNF-α and IL-6
play a key role in liver I/R injury. It has been found that
levo-tetrahydropalmatine (L-THP), an active component
of Corydalis yanhusuo, can inhibit the release of TNF-α and
IL-6 induced by liver I/R, and this protective effect is partly
dependent on the inhibition of the TNF-α-mediated ERK/
NF-κB pathway [19]. Similarly, astragaloside IV (AS-IV), a
small molecular saponin, protects liver against ischemia-
reperfusion injury by inhibiting the activation of NF-κB in
the reperfusion phase and reducing TNF-α [20]. Liu et al.
found that Xuebijing (XBJ) with protective function of
liver I/RI is largely due to its direct effect on the activation of
hepatocyte inflammasomes and caspase-1-dependent IL-1β
production, in addition to affecting the production of in-
flammatory factors/chemokines by Kupffer cells through
NF-κb-dependent mechanisms [21].
2.3. Antiapoptosis. Oxidative stress and/or mitochondrial
dysfunction induced by hepatic ischemia reperfusion can
eventually activate apoptotic cascade. Caspase-3 and -8 are
key members of the cysteine-aspartate-specific protease
family and have been shown to be essential for apoptosis
[34]. Hepatocyte apoptosis is one of the most important cell
death types in the process of liver I/R injury [35]. .e ac-
tivation of caspase-3 and caspase-8 was found in various
apoptotic cells [36], and the upregulation of caspase-3 and
caspase-8 was also found in I/R-induced liver injury, indi-
cating that caspase-mediated apoptosis is essensial in organ
I/R injury [37]. In addition to the caspase pathway, Bcl-2
family proteins also play a key role in the regulation of
neuronal apoptosis. .e following studies have demon-
strated that TCMs have an effective performance in hepatic
ischemic reperfusion injury through the antiapoptosis
pathway.
Moreover, HupA, an alkaloid extracted from Huperzia
serrata, can reduce liver I/R damage by reducing the ex-
pression of apoptosis-related proteins caspase-3, Bcl-2, and
Bax [14]. .e antiapoptotic effect of GP, the main ingredient
of Gynostemma pentaphyllum, is related to the inhibition of
I/R-induced increase in the activities of proapoptotic pro-
teins Bax, cytochrome c, and caspase-3/8, as well as the
Evidence-Based Complementary and Alternative Medicine 3
decrease in the level of antiapoptotic protein Bcl-2 [15]. In
Wang’s study, it was shown that the Ginkgo biloba Dropping
Pill (GBDP) can inhibit the expression of apoptosis-related
protein markers in vitro. Consistent with the results of in
vitro experiments, animal experiments confirmed that
GBDP can downregulate the expression of proapoptotic
proteins and reduce hepatocyte apoptosis caused by liver
I/R injury [22].
2.4. Inhibition of Endoplasmic Reticulum Stress. Endoplasmic
reticulum (ER) stress refers to the continuous accumulation
of misfolded or unfolded proteins in the endoplasmic re-
ticulum lumen, which activate the unfolded protein response
(UPR) under pathological conditions. In a steatotic liver,
endoplasmic reticulum stress is considered to be the main
cause of posttransplant injury [38].
Zhang et al. found that berberine (BBR), a compound
derived from the traditional Chinese medicine plants, in-
hibits endoplasmic reticulum stress-mediated phagocytosis
in steatotic liver transplantation. It is the first report that
addresses the protective function of BBR on steatosis liver
transplantation, but the specific mechanism involved still
remains unclear [23]. Besides, saffron ethanol extract can
also relieve the endoplasmic reticulum stress and protein
ubiquitination induced by liver I/R [8].
3. Conclusions and Prospects
.rough this review, we get some similarities from articles
published in recent years. Firstly, traditional Chinese
medicines with protective effect of liver I/R injury are mostly
the main active substances of Chinese medicines. Secondly,
TCMs protect liver function via multiple mechanisms, in-
cluding antioxidation, anti-inflammatory, inhibition of cell
apoptosis, and inhibition of endoplasmic reticulum stress, of
which antioxidant and anti-inflammatory effects are most
commonly reported. Also, the NF-κB signaling pathway is
the most frequently involved signaling pathway. .irdly,
different components of traditional Chinese medicines may
exert protective effects through different mechanisms.
Lastly, the specific signaling pathways involved in these
mechanisms remain unkown.
In conclusion, traditional Chinese medicine has
protective effect on liver I/R injury. However, future
research should pay more attention to in-depth mechanism
exploration rather than just descriptive observations.
Moreover, research should also clarify which compo-
nents of Chinese medicine mainly play a protective role
in liver ischemia reperfusion. Furthermore, it is neces-
sary to conduct experiments both in vivo and in vitro to
increase the convincing power of the experimental re-
sults. Finally, large sample, randomized, double-blind,
placebo-controlled, and multicenter clinical trials are
still in need.
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